© Springer-Verlag Italia 2015Carlo Trombetta, Giovanni Liguori and Michele Bertolotto (eds.)Management of Gender Dysphoria10.1007/978-88-470-5696-1_6 6. Etiopathogenetic Hypotheses of Transsexualism Randi Ettner1 (1) Department of Psychology, New Health Foundation Worldwide, 1214 Lake Street, Evanston, IL 60201, USA …
© Springer-Verlag Italia 2015Carlo Trombetta, Giovanni Liguori and Michele Bertolotto (eds.)Management of Gender Dysphoria10.1007/978-88-470-5696-1_1 1. Introduction: My Personal Experience Through the Years Carlo Trombetta1 (1) Department of Urology, University of Trieste, Cattinara Hospital, Trieste, Italy …
Fig. 3.1 Presentation of nerve fascicles targeted by RF energy at various time points post treatment. Nerve fascicle necrosis and vacuolisation can be found as early as 6 h after…
Fig. 15.1 Illustration of renal enervation. The netter collection of medical illustrations, volume 6, kidneys, ureters, and urinary bladder, page 27 (With permission from Elsevier, Health Sciences Division) Verve Medical…
Fig. 16.1 Longitudinal sections of the 30 day endpoint histology of the sciatic nerve bundles from animals injected with (a) NW2013 and (b) normal saline Overall, agent NW2013 was determined…
Fig. 9.1 The paradise renal denervation system. (a) Paradise generator. (b) Paradise catheter: ultrasound transducer within cooling balloon. (c) The paradise system in situ (artistic rendering) Paradise Generator The Paradise…
Fig. 13.1 Schematic drawings showing sequence of chemical denervation with EtOH. The upper left panel shows the anatomy of the mid-portion of the renal artery and shows no significant organs…
Fig. 10.1 The TIVUS™ System (Console and Multidirectional Catheter) (Printed with permission from Cardiosonic) Fig. 10.2 Fluoroscopic image of the multidirectional TIVUS™ Catheter in the renal artery introduced over a…
Fig. 12.1 Beta-Cath™ 3.5F system Limitations of RF Ablation Ample data exists to support the concept of renal sympathetic nerve RF ablation for the treatment of resistant hypertension [1, 2]….
Fig. 23.1 Sympathetic activity measured by MSNA in normotensive controls (NT), diabetes mellitus type 2 (DM2), hypertension (HTN) and metabolic syndrome (HTN + DM2) (Modified from Huggett et al. [1])…
